Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HPQ | Common Stock | Options Exercise | $0 | +6.47K | +31.28% | $0.00 | 27.2K | Apr 1, 2024 | Direct |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | HPQ | Restricted Stock Units | Options Exercise | -6.47K | -100% | 0 | Apr 1, 2024 | Common Stock | 6.47K | Direct | F1, F2 |
Id | Content |
---|---|
F1 | Each restricted stock unit ("RSU") represents a contingent right to receive one share of HP common stock. |
F2 | As previously reported, on 05/18/2017, the reporting person was granted 5,325 RSUs, all of which vested on the one year anniversary of the grant date. The reporting person elected to defer the receipt of HP common stock upon the vesting of RSUs until 04/01/2024. Dividend equivalent rights accrue with respect to these RSUs when and as dividends are paid on HP common stock. The number of derivative securities in column 5 includes 1,145 vested dividend equivalent rights. |